FDA Confers with International Counterparts to Advance Regulatory Science Posted on December 16, 2013 by FDA Voice By: Margaret A. Hamburg, M.D.

I have recently returned from the 8th International Summit of Heads of Medicines Regulatory Agencies, which was hosted on December 3-6, 2013, by the Netherlands’ Medicines Evaluation Board in Amsterdam. These annual meetings are an important forum for the exchange of information, views and regulatory strategies among the chief executives of major and like-minded medicines regulatory agencies. I was particularly pleased to be able to contribute to these discussions as a speaker on a panel on regulatory science together with Dr. Tatsuya Konda, M.D., Ph.D., the chief executive of Japan’s Pharmaceuticals and Medical Devices Agency.

- See more at: http://blogs.fda.gov/fdavoice/index.php/2013/12/fda-confers-with-international-counterparts-to-advance-regulatory-science/?source=govdelivery&utm_medium=email&utm_source=govdelivery#sthash.76zi5dJZ.dpuf